+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Failure POC & LOC Devices Market - Global Forecast 2026-2032- Product Image
Heart Failure POC & LOC Devices Market - Global Forecast 2026-2032- Product Image
Sale

Heart Failure POC & LOC Devices Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5639846
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Heart Failure POC & LOC Devices Market is projected to reach USD 348.06 Million in 2026. It is expected to continue growing at a CAGR of 13.77%, reaching USD 744.92 Million by 2032.

Heart failure point-of-care (POC) and lab-on-chip (LOC) devices are moving from adjunct diagnostics to essential tools for faster triage, risk stratification, and longitudinal disease management. Global heart failure prevalence is commonly reported at more than 64 million people, while the CDC reports that approximately 6.7 million U.S. adults aged 20 and older live with heart failure, underscoring the need for rapid, decentralized testing.

The field is anchored by natriuretic peptide testing, including BNP and NT-proBNP, which is supported by major clinical guidelines for diagnosis, exclusion, and risk assessment in suspected heart failure. Adoption is expanding as emergency departments, primary care clinics, home care programs, ambulatory settings, and community-based care teams seek faster decisions, fewer avoidable admissions, and improved monitoring of high-risk patients.

Transformative Shifts in the Heart Failure Diagnostics Landscape

The heart failure diagnostics landscape is shifting toward decentralized, connected, and miniaturized testing. Microfluidics, biosensors, immunoassay miniaturization, and smartphone-enabled readers are improving turnaround time and reducing dependence on centralized laboratories, especially where urgent dyspnea evaluation, congestion assessment, and therapy optimization require fast results.

Healthcare systems are also prioritizing value-based care, hospital-at-home models, and remote patient monitoring. These shifts support integrated heart failure pathways where POC and LOC devices work alongside echocardiography, ECG, wearable sensors, electronic health records, and guideline-directed medical therapy to reduce diagnostic delays and support timely escalation or de-escalation of care.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is strengthening heart failure POC and LOC devices by improving signal processing, assay interpretation, risk scoring, and workflow prioritization. AI-enabled analytics can combine biomarker values with vital signs, ECG patterns, comorbidities, medications, renal function indicators, and prior utilization data to support earlier identification of decompensation and higher-risk presentations.

The cumulative impact is most valuable when algorithms are clinically validated, explainable, bias-assessed, and integrated into physician-supervised workflows. Regulatory expectations from guidance on software as a medical device, good machine learning practice, cybersecurity, data governance, and post-market monitoring are shaping responsible deployment across connected heart failure diagnostics.

Key Regional Insights Across Global Markets

North America remains a leading adoption region due to mature emergency care networks, high heart failure burden, established reimbursement pathways, and strong digital health infrastructure. Europe is driven by guideline-based natriuretic peptide testing, aging populations, laboratory quality standards, and national programs focused on integrated chronic disease care across hospital and community settings.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in diagnostics access, connected care, local manufacturing, and chronic cardiovascular disease management. Latin America shows demand for cost-effective POC testing in urban hospitals, public health systems, and underserved areas, while the Middle East is advancing premium hospital infrastructure, digital transformation, and specialist cardiovascular services. Africa presents long-term opportunity where portable diagnostics can improve access to heart failure assessment despite workforce shortages, fragmented referral systems, and limited centralized laboratory capacity.

Key Group Insights for Strategic Market Prioritization

The European Union benefits from harmonized medical device regulation, large aging populations, structured clinical pathways, and strong guideline adoption, making it an important environment for validated POC and LOC heart failure diagnostics. G7 countries lead in reimbursement maturity, clinical research intensity, quality standards, and adoption of connected care models for chronic cardiovascular disease.

BRICS markets are important for scalable access, local production, and affordable testing models suited to large and diverse patient populations. ASEAN countries are prioritizing diagnostics access, mobile health integration, and primary care strengthening, while GCC systems are investing in advanced hospital networks, digital transformation, and chronic disease programs. NATO member markets add relevance through procurement resilience, cybersecurity expectations, interoperability, and secure medical infrastructure for connected diagnostic platforms.

Key Country Insights Across Major Heart Failure Markets

The United States leads in clinical adoption due to strong emergency medicine use cases, CDC-recognized disease burden, established biomarker testing practices, and growing remote monitoring programs. Canada emphasizes equitable access and chronic disease management, while Mexico and Brazil show rising need for affordable decentralized diagnostics as cardiovascular disease burdens expand and health systems seek faster triage outside centralized laboratories.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support evidence-based natriuretic peptide testing through guideline-led care pathways, aging populations, and established hospital networks, while Russia faces a need for scalable diagnostics across dispersed populations and variable regional access. China and India are priority growth environments due to population size, urban hospital expansion, and improving diagnostics access; Japan, South Korea, and Australia are advanced adopters shaped by aging demographics, sophisticated hospitals, quality-focused regulation, and digital health readiness.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated assays, fast turnaround time, interoperability with electronic health records, and usability across emergency, outpatient, rural, and home-based settings. Devices that combine biomarker accuracy with connectivity, embedded quality controls, cybersecurity, and clear clinical decision support will be better positioned for guideline-aligned adoption.

Organizations should build evidence packages demonstrating diagnostic performance, workflow impact, reduced time to treatment, readmission-related outcomes, and health economic value. Partnerships with hospitals, payers, home care providers, emergency networks, and public health systems can accelerate procurement, while localized pricing, service support, training, and manufacturing strategies can improve access in emerging markets.

Research Methodology for Evidence-Based Market Analysis

The research methodology should combine primary interviews with cardiologists, emergency physicians, laboratory directors, device developers, payers, procurement leaders, home care providers, and digital health stakeholders. Secondary validation should include peer-reviewed cardiology literature, clinical guideline statements from major societies, regulatory databases, hospital utilization data, reimbursement policies, and public health sources such as WHO and CDC.

Market interpretation should triangulate clinical demand, installed care pathways, reimbursement readiness, diagnostic accuracy requirements, technology maturity, regional access gaps, regulatory expectations, and competitive positioning. This approach supports defensible, evidence-based insights without relying on unsupported projections and helps identify where POC and LOC devices can create measurable clinical and operational value.

Conclusion and Strategic Outlook

Heart failure POC and LOC devices are becoming central to faster diagnosis, targeted triage, and continuous management of a high-burden chronic condition. Their value is strongest when rapid biomarker testing is paired with connected workflows, validated AI, quality assurance, and integrated care models that support timely clinical decisions.

The strategic outlook is supported by aging populations, rising cardiovascular disease prevalence, emergency department pressure, and health system efforts to reduce avoidable admissions. Organizations that deliver accurate, affordable, interoperable, secure, and clinically trusted solutions will be well positioned to shape the next phase of decentralized heart failure care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Heart Failure POC & LOC Devices Market, by Test Type
7.1. Introduction
7.2. Genomic Testing
7.3. Metabolomic Testing
7.4. Proteomic Testing
8. Heart Failure POC & LOC Devices Market, by Device Type
8.1. Introduction
8.2. Diagnostic Devices
8.2.1. Cardiac Biomarker Analyzers
8.2.2. Cardiac Imaging Devices
8.2.3. Electrocardiogram (ECG)
8.3. Wearable Devices
8.3.1. External Defibrillator
8.3.2. Heart Rate Monitors
9. Heart Failure POC & LOC Devices Market, by Technology
9.1. Introduction
9.2. Biosensor-based systems
9.3. Imaging & impedance-based platforms
9.4. Immunoassays
9.5. Nucleic acid-based platforms
10. Heart Failure POC & LOC Devices Market, by End User
10.1. Introduction
10.2. Assisted Living Healthcare
10.3. Home Care Facilities
10.4. Hospitals & Clinics
10.5. Laboratory
11. Heart Failure POC & LOC Devices Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Heart Failure POC & LOC Devices Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Heart Failure POC & LOC Devices Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. ACON Laboratories Inc.
15.3. Becton, Dickinson and Company
15.4. Bio-Rad Laboratories, Inc.
15.5. bioMérieux S.A.
15.6. Boston Scientific Corporation
15.7. Cipla Limited
15.8. Danaher Corporation
15.9. F. Hoffmann-La Roche Ltd.
15.10. Fukuda Denshi Co., Ltd.
15.11. Jant Pharmacal Corporation
15.12. Johari Digital India Limited by Syrma SGS
15.13. Koninklijke Philips N.V.
15.14. LifeSign LLC
15.15. LifeSync
15.16. Luminex Corporation by DiaSorin S.p.A.
15.17. Mitsubishi Chemical Group Corporation
15.18. Nexus Dx, Inc
15.19. Nihon Kohden Corporation
15.20. Quidel Corporation
15.21. Schiller AG
15.22. Shenzhen EDAN Instrument Co., Ltd.
15.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
15.24. Siemens Healthineers AG
15.25. Spectral Diagnostics Inc.
15.26. Trinity Biotech PLC
List of Figures
FIGURE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL GENOMIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL GENOMIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL GENOMIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL METABOLOMIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL METABOLOMIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL METABOLOMIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PROTEOMIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PROTEOMIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PROTEOMIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKER ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKER ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKER ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CARDIAC IMAGING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CARDIAC IMAGING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CARDIAC IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ELECTROCARDIOGRAM (ECG) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ELECTROCARDIOGRAM (ECG) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ELECTROCARDIOGRAM (ECG) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL WEARABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL WEARABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL WEARABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL EXTERNAL DEFIBRILLATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL EXTERNAL DEFIBRILLATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL EXTERNAL DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HEART RATE MONITORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HEART RATE MONITORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HEART RATE MONITORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL BIOSENSOR-BASED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL BIOSENSOR-BASED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BIOSENSOR-BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL IMAGING & IMPEDANCE-BASED PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL IMAGING & IMPEDANCE-BASED PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL IMAGING & IMPEDANCE-BASED PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID-BASED PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID-BASED PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID-BASED PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ASSISTED LIVING HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ASSISTED LIVING HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ASSISTED LIVING HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL HOME CARE FACILITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL HOME CARE FACILITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL HOME CARE FACILITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL LABORATORY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LABORATORY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL LABORATORY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 64. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 69. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 71. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 72. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 73. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 74. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 75. NORTH AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 76. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 78. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 79. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 80. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 81. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 82. LATIN AMERICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 83. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 85. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 86. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 87. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 88. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 89. EUROPE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 90. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 92. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 93. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 94. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 95. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 96. MIDDLE EAST HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 97. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 99. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 100. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 101. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 102. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 103. AFRICA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 107. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 108. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 109. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 110. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 111. ASEAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 112. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 114. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 115. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 116. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 117. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 118. GCC HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 128. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 129. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 130. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 131. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 132. BRICS HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 135. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 136. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 137. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 138. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 139. G7 HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 142. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 143. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 144. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 145. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 146. NATO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 149. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 150. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 151. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 152. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 153. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. UNITED STATES HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 156. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 157. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 158. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 159. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 160. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. CANADA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 163. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 164. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 165. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 166. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 167. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 168. MEXICO HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 170. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 171. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 172. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 173. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 174. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 175. BRAZIL HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 176. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 177. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 178. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 179. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 180. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 181. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 182. UNITED KINGDOM HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 184. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 185. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 186. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 187. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 188. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. GERMANY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 191. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 192. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 193. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 194. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 195. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. FRANCE HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 197. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 198. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 199. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 200. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 201. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 202. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 203. RUSSIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 205. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 206. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 207. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 208. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 209. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. ITALY HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 212. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 213. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 214. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 215. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 216. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 217. SPAIN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 220. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 221. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 222. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 223. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. CHINA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 227. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 228. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 229. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 230. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 231. INDIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 234. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 235. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 236. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 237. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. JAPAN HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 241. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 242. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 243. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 244. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. AUSTRALIA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 248. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 249. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2017-2032 (USD MILLION)
TABLE 250. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2017-2032 (USD MILLION)
TABLE 251. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 252. SOUTH KOREA HEART FAILURE POC & LOC DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 254. GLOBAL HEART FAILURE POC & LOC DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux S.A.
  • Boston Scientific Corporation
  • Cipla Limited
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fukuda Denshi Co., Ltd.
  • Jant Pharmacal Corporation
  • Johari Digital India Limited by Syrma SGS
  • Koninklijke Philips N.V.
  • LifeSign LLC
  • LifeSync
  • Luminex Corporation by DiaSorin S.p.A.
  • Mitsubishi Chemical Group Corporation
  • Nexus Dx, Inc
  • Nihon Kohden Corporation
  • Quidel Corporation
  • Schiller AG
  • Shenzhen EDAN Instrument Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Spectral Diagnostics Inc.
  • Trinity Biotech PLC

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 348.06 Million
Forecasted Market Value ( USD ) by 2032 $ 744.92 Million
Compound Annual Growth Rate13.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Heart Failure POC and LOC Devices - Global Strategic Business Report - Product Image

Heart Failure POC and LOC Devices - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Heart Failure POC And LOC Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Heart Failure POC And LOC Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Heart Failure POC And LOC Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
United States Heart Failure POC and LOC Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

United States Heart Failure POC and LOC Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • United States
From
Cardiac POC Testing Devices Market - Global Forecast 2026-2032 - Product Image

Cardiac POC Testing Devices Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From

About the Heart Failure POC Device Market

The Heart Failure POC Device market is a segment of the Cardiovascular Devices industry. It includes devices used to monitor and diagnose heart failure, such as implantable hemodynamic monitors, implantable cardiac monitors, and portable ECG monitors. These devices are used to detect changes in heart rate, rhythm, and blood pressure, and to provide early warning of heart failure. They are designed to be used in the home or in a clinical setting. The Heart Failure POC Device market is expected to grow due to the increasing prevalence of heart failure and the need for early diagnosis and treatment. The market is also driven by technological advancements, such as the development of miniaturized and wireless devices, and the increasing availability of telemedicine services. Some companies in the Heart Failure POC Device market include Abbott, Medtronic, Philips, and St. Jude Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.